1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Two rounds: Round 1 external deadline July 30, 2025 (closed); Round 2 external deadline February 4, 2026. Page states '2025 rounds are closed and awaiting outcomes.' A 2026 ICTC page is referenced for future applicants.
MRFF – 2025 International Clinical Trial Collaborations Grant Opportunity (GO7555) is sponsored by National Health and Medical Research Council (NHMRC). Supports Australian involvement in international collaborative clinical trials to provide evidence on the effectiveness of novel health treatments.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
MRFF 2025 International Clinical Trial Collaborations - Research support - University of Queensland MRFF 2025 International Clinical Trial Collaborations Medical Research Future Fund Release of Funding Rules: 20 February 2025 Proposals open in Sapphire: 20 February 2025 UQ R&I NOI Close: 2 July 2025 Minimum data requirements in Sapphire: 5pm ACT time, 2 July 2025 Applications due to UQ R&I: 9 July 2025 Applications close: 5pm ACT time 30 July 2025 Anticipated announcement of outcomes: December 2025 Release of Funding Rules: 20 February 2025 Proposals open in Sapphire: 20 February 2025 UQ R&I NOI Close: 10 December 2025 Minimum data requirements in Sapphire: 5pm ACT time, 10 December 2025 Applications due to UQ R&I: 14 January 2026 Applications close: 5pm ACT time, 4 February 2026 The International Clinical Trials Collaboration will support medical research and medical innovation projects that: promote Australian involvement in international collaborative investigator-initiated clinical trials research through the establishment and co-ordination of clinical trial site/s in Australia.
provide high-quality evidence of the effectiveness of novel health treatments, drugs or devices in 'usual care' settings, which will support a decision on whether to deliver the intervention in an Australian setting. Applications to this grant opportunity must propose a clinical trial in Australia in collaboration with international counterparts. The clinical trial should not have commenced recruitment at the Australian trial site/s.
A person must not be named as a Chief Investigator (CI) on more than one application submitted to a Round of this grant opportunity. Step 1: Internal Notice of Intent (NOI) All researchers intending to submit an MRFF application are required to submit an internal Notice of Intent. NOIs will be collated centrally and distributed to Faculties and Institutes in order to provide maximum support to the UQ research community.
Submit UQ Notice of Intent Step 2. Sapphire updates and scheme reading Register for Sapphire and update your full profile 'My Profile and CV'. All Chief Investigators (CI) and Associate Investigators (AI) will need to have an active Sapphire account.
Any team members without a Sapphire account should request one as early as possible. The NHMRC require at least three working days to create new Sapphire accounts. Download guidelines and application templates from GrantConnect.
Familiarise yourself with the key MRFF, NHMRC and UQ documentation (see below). Step 3. Completing the application Ensure all required data is entered into the application before the Minimum Data deadline (see Key dates above).
Applications that do not meet this deadline will not be able to proceed. Step 4. UQ R&I internal review and feedback Ahead of internal review, ensure all online components are complete and valid in Sapphire and CIA has initiated the Certification process.
Application errors will be signalled and can be corrected during the Certification stage. To initiate internal review, email the UQ Research Office at mrffgrants@research. uq.
edu. au with your completed MRFF Funding Application Certification form (below). UQ Research Office will review your application and provide you with feedback as requested in NOI (eligibility & compliance; refinement; or content grantscraft).
When your application is complete and fully compliant, the UQ Research Office will submit the application to the NHMRC through Sapphire. Most MRFF applications administered in Sapphire will not require a letter of support from UQ. This is usually only necessary if UQ is committing cash to the project.
We ask that UQ researchers submit draft letters for signing to us no later than two weeks before the external closing date. We strongly recommend working with your local school/institute research professionals to complete this process. We encourage applicants to provide drafts of partner letters of support for review by the Research office before organising their final signature to ensure eligibility and compliance.
A template partner letter of support is provided below. The administering organisation should provide you with a draft letter of support. We recommend you work with your local research support to complete the letter.
Complete and sign an MRFF Funding Application Certification form (see below), and get it countersigned by your Head of School/Institute. Submit both to mrffgrants@research. uq.
edu. au , along with evidence for any additional co-contributions. Readership and researcher support Before applying, we recommend you: Familiarise yourself with the framework for Applying for Competitive Research Grants at UQ.
Contact your faculty or institute research manager for advice on peer readership programs. Access the UQ R&I Grants Library , a helpful resource of past successful proposals.
Read the UQ R&I Grant writing advice and strategy website for tips on preparing your application Before applying, please review the full suite of documents available from GrantConnect, the Australian Government grants information system and: Grant Connect GO7555 (Guidelines and application templates should be downloaded from here before commencing application) MRFF Monitoring, Evaluation and Learning Strategy 2020-21 to 2023-24 NHMRC Research Classification Guides UQ MRFF Application Certification Form (DOCX, 70.
5 KB) *updated 29 Apr 2025 UQ MRFF Declaration of Interests (DOCX, 21. 9 KB) UQ 2025 MRFF Letter of Support template (DOCX, 38.
3 KB) UQ How to Guide for MRFF Grants (PDF, 417 KB) MRFF 2026 Consumer-Led Research MRFF 2026 Early to Mid-Career Researchers MRFF 2026 Genomics Health Futures MRFF 2026 Indigenous Health Research - Empowering Community-Controlled Research MRFF 2026 International Clinical Trial Collaborations MRFF 2026 Mental Health Research MRFF 2026 National Critical Research Infrastructure MRFF 2026 Post-Acute Sequelae of COVID-19 MRFF 2026 Traumatic Brain Injury MRFF 2025 Clinical Trials Activity MRFF 2025 Genomics Health Futures MRFF 2025 Research Data Infrastructure MRFF 2025 Cardiovascular Health MRFF 2025 Dementia, Ageing and Aged Care MRFF 2025 Stem Cell Therapies MRFF 2025 Brain Cancer Research MRFF 2025 Cardiovascular Disease and Diabetes Models of Care MRFF 2025 Cardiovascular Disease and Diabetes Risk Prediction and Data Solutions MRFF 2025 International Clinical Trial Collaborations MRFF 2025 Childhood Mental Health Research MRFF Frontier Health and Medical Research Program MRFF 2025 Early to Mid-Career Researchers MRFF 2025 Mental Health and Climate Change MRFF 2024 Clinical Trial Enabling Infrastructure MRFF 2024 National Critical Research Infrastructure MRFF 2024 Rapid Applied Research Translation Scheme and Sapphire queries mrffgrants@research.
uq. edu. au Pre-Award Researcher Identified Opportunities Team
According to the current listing, eligibility includes: Researchers and institutions involved in international clinical trials. Confirm the full requirements in the official notice before applying.
MRFF – 2025 International Clinical Trial Collaborations Grant Opportunity (GO7555) is funded by National Health and Medical Research Council (NHMRC). Verify program details on the funder's official page before applying.
This listing is flagged as international in scope. Check the official notice for country-specific restrictions before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleOn September 4, 2026, HRSA awarded $11.2 million through the Rural Residency Planning and Development program to build 15 new physician residencies across 14 states. Since 2019 the program has invested nearly $77 million, producing 66 accredited programs and 818 approved positions. Here is what the conversion rate reveals, why the specialty mix is narrowing, and how to build a competitive application for the next cycle.
Read articleHRSA-27-017 closes September 29, 2026 and HRSA-27-084 closes November 16, with $20,960,000 and $16,000,000 respectively. The award floors and ceilings are not budget guesses — they are resident headcounts at the $160,000 interim per-resident rate. Read them that way and the eligibility question answers itself.
Read article